Article ID Journal Published Year Pages File Type
8226405 International Journal of Radiation Oncology*Biology*Physics 2012 7 Pages PDF
Abstract
The PrC-210 aminothiol, with no detectable nausea/vomiting or hypotension side effects in these preclinical models, is a logical candidate for human drug development to use in healthy humans in a wide variety of radioprotection settings, including medical radiation, space travel, and nuclear accidents.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses
Authors
, , ,